Skip to main content

Vira Shield 6+L5 HB

This page contains information on Vira Shield 6+L5 HB for veterinary use.
The information provided typically includes the following:
  • Vira Shield 6+L5 HB Indications
  • Warnings and cautions for Vira Shield 6+L5 HB
  • Direction and dosage information for Vira Shield 6+L5 HB

Vira Shield 6+L5 HB

This treatment applies to the following species:
Company: Elanco US (Farm Animal)

Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine

Killed Virus

Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin

For Use In Animals Only

Vira Shield 6+L5 HB Indications

This product has been shown to be effective for the vaccination of healthy cows against disease caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD Type 1 and BVD Type 2), parainfluenza Type 3 (PI3), and bovine respiratory syncytial (BRSV) viruses and Leptospira canicola, grippotyphosa, hardjo-bovis, icterohaemorrhagiae, and pomona. The duration of immunity against BVD Type 2 is at least 11 months and L. hardjo-bovis is at least 12 months. The duration of immunity for the remaining antigens in this product has not been established. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

This product has been shown to be effective against hardjo bovis kidney colonization, urinary shedding and reproductive tract infection. Vaccinated animals subsequently exposed to L. borgpetersenii serovar hardjo (type hardjo bovis) have been shown to clear renal infections within 8 weeks of exposure. Produced from non-cytopathic (BVD Type 1 and BVD Type 2) and cytopathic (BVD Type 1) isolates. This product is safe for use in pregnant cows and heifers.

ADJUVANT: Xtend™ SP.

Directions For Use

Shake well before using. Administer 5 mL subcutaneously. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (under the skin) in the neck. Revaccinate in 4 to 5 weeks. Vaccinate dairy cows at dry-off. Historically, annual revaccination with a single dose has been recommended for this product. The need for this booster has not been established. The presence of maternal antibody is known to interfere with the development of active immunity in calves and additional boosters will be required in most young animals. For advice on revaccination frequency, in general or in the face of maternal antibody, consultation with a veterinarian is recommended.

Precautions

Store out of direct sunlight at 2° to 8°C (35° to 46°F). DO NOT FREEZE. Use entire contents when first opened. Do not mix with other products, except as specified on the label. In case of human exposure, contact a physician. Do not vaccinate within 60 days prior to slaughter. Transient swelling may occur at the site of injection. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.

VLN/PCN 196/4465.20

Elanco US, Inc., Fort Dodge, IA 50501 USA; 1-800-428-4441

Vira Shield, Xtend, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

10 Doses

50 mL

YL102791A

50 Doses

250 mL

YL102791B

CPN: 1114099.7

ELANCO US, INC.
Distributed by ELANCO US, INC.
2500 INNOVATION WAY, GREENFIELD, IN, 46140
Customer Service:   317-276-1262
Technical Service:   800-428-4441
Website:   www.elanco.us
Email:   elanco@elanco.com
This service and data are provided "AS IS". DVMetrics and Drugs.com assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics and Drugs.com services and data. See the terms of use for further details.

Copyright © 2022 Animalytix LLC. Updated: 2021-11-29